Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure

Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride:... Adv Ther (2017) 34:1976–1988 DOI 10.1007/s12325-017-0584-x ORIGINAL RESEARCH Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure . . . . Elizabeth Ofili Inder Anand Richard Allen Williams Ola Akinboboye Liou Xu Gary Puckrein Received: May 19, 2017 / Published online: July 13, 2017 The Author(s) 2017. This article is an open access publication without any supporting outcome data. We ABSTRACT conducted an exploratory retrospective propensity-matched cohort study using Medi- Introduction: Based upon the findings of the care data to determine whether a survival dif- African-American Heart Failure Trial, the US ference exists between these treatments in Food and Drug Administration approved the medication-adherent patients. fixed-dose combination of isosorbide dinitrate Methods: Black Medicare beneficiaries with HF (ISDN) and hydralazine hydrochloride (HYD) were matched with Medicare Part D data to (FDC-ISDN/HYD) as a new drug for treatment of identify patients with prescriptions to heart failure (HF) in self-identified African FDC-ISDN/HYD or the off-label combinations. Americans. According to the FDA, FDC-ISDN/ Only patients with 1-year adherence levels HYD has no therapeutic equivalent. However, C80% were included in the analysis. Propen- off-label combinations of the separate generic sity-matched scoring created two http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Therapy Springer Journals

Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure

Loading next page...
 
/lp/springer_journal/fixed-dose-versus-off-label-combination-of-isosorbide-dinitrate-plus-RMR00SCbGq
Publisher
Springer Healthcare
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Oncology; Cardiology; Rheumatology; Endocrinology; Pharmacology/Toxicology
ISSN
0741-238X
eISSN
1865-8652
D.O.I.
10.1007/s12325-017-0584-x
Publisher site
See Article on Publisher Site

Abstract

Adv Ther (2017) 34:1976–1988 DOI 10.1007/s12325-017-0584-x ORIGINAL RESEARCH Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure . . . . Elizabeth Ofili Inder Anand Richard Allen Williams Ola Akinboboye Liou Xu Gary Puckrein Received: May 19, 2017 / Published online: July 13, 2017 The Author(s) 2017. This article is an open access publication without any supporting outcome data. We ABSTRACT conducted an exploratory retrospective propensity-matched cohort study using Medi- Introduction: Based upon the findings of the care data to determine whether a survival dif- African-American Heart Failure Trial, the US ference exists between these treatments in Food and Drug Administration approved the medication-adherent patients. fixed-dose combination of isosorbide dinitrate Methods: Black Medicare beneficiaries with HF (ISDN) and hydralazine hydrochloride (HYD) were matched with Medicare Part D data to (FDC-ISDN/HYD) as a new drug for treatment of identify patients with prescriptions to heart failure (HF) in self-identified African FDC-ISDN/HYD or the off-label combinations. Americans. According to the FDA, FDC-ISDN/ Only patients with 1-year adherence levels HYD has no therapeutic equivalent. However, C80% were included in the analysis. Propen- off-label combinations of the separate generic sity-matched scoring created two

Journal

Advances in TherapySpringer Journals

Published: Jul 13, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off